» Articles » PMID: 12453130

Comparison of Three Different Preparations of Platelet Concentrates for Growth Factor Enrichment

Overview
Specialty Dentistry
Date 2002 Nov 28
PMID 12453130
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to compare three different systems for preparing platelet concentrates: two commercially available bed-side techniques (Curasan system and PCCS) and a procedure used routinely in transfusion medicine. Platelet concentrates were prepared from venous blood of 12 healthy male volunteers using the three different systems. Platelet and leucocyte counts were performed and platelet derived growth factor and transforming growth factor beta were assayed by enzyme linked immunoassay. Handling was also considered. The three systems were able to collect 19.0 +/- 16.6% (laboratory system), 41.9 +/- 9.7% (Curasan system) and 49.6 +/- 21.0% (PCCS) of the absolute number of platelets which were originally in the venous blood volume within the platelet concentrate. Due to the amount of plasma which is left in the platelet concentrate portion, the platelet concentration could be increased between 1.4 +/- 1.3 times (laboratory system), 5.0 +/- 2.3 times (PCCS) and 11.7 +/- 2.4 times (Curasan system) compared to the venous blood. The amount of growth factors correlated with the number of platelets within the platelet concentrates. The two systems for intraoperative use are similar in their effects on the platelets. The absolute gain of platelets seems to be the highest with the PCCS; the highest concentration of platelets per micro L is gained with the Curasan system. The laboratory system may offer an alternative if an intraoperative system is not available.

Citing Articles

A review of platelet-rich plasma for enteric fistula management.

Liang S, Zheng Z, Li Y, Yang Y, Qin L, Zhao Z Front Bioeng Biotechnol. 2023; 11:1287890.

PMID: 38033816 PMC: 10685294. DOI: 10.3389/fbioe.2023.1287890.


Comparing efficacies of autologous platelet concentrate preparations as mono-therapeutic agents in intra-bony defects through systematic review and meta-analysis.

Varshney S, Dwivedi A, Dwivedi V J Oral Biol Craniofac Res. 2023; 13(6):671-681.

PMID: 37711544 PMC: 10497996. DOI: 10.1016/j.jobcr.2023.08.007.


Platelet-derived concentrates influence human keratinocyte proliferation and induce wound healing in a prospective case series of chronic wounds of different entities .

Paulmann A, Strauss S, Limbourg A, Vogt P Innov Surg Sci. 2022; 7(2):45-58.

PMID: 36317012 PMC: 9574654. DOI: 10.1515/iss-2022-0011.


Platelet-Rich Plasma in the Treatment of Facet Mediated Low Back Pain: A Comprehensive Review.

Patel A, Koushik S, Schwartz R, Gritsenko K, Farah F, Urits I Orthop Rev (Pavia). 2022; 14(4):37076.

PMID: 35910548 PMC: 9329057. DOI: 10.52965/001c.37076.


Histological Examination of Retrieved ePTFE Membranes Following Regenerative Surgery of Intrabony Defects Treated with Platelet-rich Plasma and Bone Substitutes.

Dori F, Sculean A, Takacs D, Suba Z Oral Health Prev Dent. 2022; 20:133-140.

PMID: 35285602 PMC: 11641222. DOI: 10.3290/j.ohpd.b2805491.